Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-16

Clinical Trial Update: Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State [NA]

View source ↗

Summary

Completed bioequivalence study of eltrombopag olamine tablets in healthy subjects under fed conditions. The study was conducted by Chia Tai Tianqing Pharmaceuti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eltrombopag olamine tablets (eltrombopag olamine)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Thrombocytopenia | NA | Status: COMPLETED